Pfizer (PFE) Raw Materials (2009 - 2019)
Pfizer (PFE) posted quarterly Raw Materials of $560.0 million for Q1 2019, down 32.12% year-over-year from $825.0 million in Q1 2018, and up 2.56% quarter-over-quarter from $546.0 million in Q4 2018.
Pfizer (PFE) Raw Materials (2009 - 2019) Analysis & Trends
Pfizer (PFE) has reported Raw Materials for 11 consecutive years, with $560.0 million the latest figure, recorded in Q1 2019.
- In Q1 2019, Raw Materials fell 32.12% year-over-year to $560.0 million; the TTM figure through Mar 2019 stood at $560.0 million (down 32.12% YoY), while the FY2018 annual figure was $546.0 million, down 30.71% from the prior year.
- Raw Materials advanced to $560.0 million in Q1 2019 per PFE's latest filing, from $546.0 million in the prior quarter.
- Across five years, Raw Materials topped out at $950.0 million in Q3 2016 and bottomed at $475.0 million in Q1 2015.
- Historically, Raw Materials has averaged $741.2 million across 5 years, with a median of $793.0 million in 2016.
- Annual changes were most pronounced in 2016 — Raw Materials surged 84.82% — and 2019, when it plunged 32.12%.
- Pfizer's Raw Materials stood at $867.0 million in 2015, then slipped by 8.54% to $793.0 million in 2016, then fell by 0.63% to $788.0 million in 2017, then plunged by 30.71% to $546.0 million in 2018, then climbed by 2.56% to $560.0 million in 2019.
- Business Quant data shows PFE's Raw Materials at $560.0 million in Q1 2019, $546.0 million in Q4 2018, and $839.0 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 560.00 Mn |
| Dec 31, 2018 | 546.00 Mn |
| Sep 30, 2018 | 839.00 Mn |
| Jul 1, 2018 | 776.00 Mn |
| Apr 1, 2018 | 825.00 Mn |
| Dec 31, 2017 | 788.00 Mn |
| Dec 31, 2016 | 793.00 Mn |
| Oct 2, 2016 | 862.00 Mn |
| Jul 3, 2016 | 950.00 Mn |
| Apr 3, 2016 | 840.00 Mn |
| Dec 31, 2015 | 867.00 Mn |
| Jun 28, 2015 | 514.00 Mn |
| Mar 29, 2015 | 475.00 Mn |
| Dec 31, 2014 | 510.00 Mn |
| Sep 28, 2014 | 557.00 Mn |
| Jun 29, 2014 | 588.00 Mn |
| Mar 30, 2014 | 527.00 Mn |
| Dec 31, 2013 | 505.00 Mn |
| Sep 29, 2013 | 410.00 Mn |
| Jun 30, 2013 | 576.00 Mn |